Table 1.
Baseline characteristics of the study participants stratified by NAFLD
| Variables | NAFLD | Non-NAFLD | P value |
|---|---|---|---|
| N | 527 | 776 | |
| Sex (%men) | 454(86.15%) | 492(63.40%) | P < 0.0001 |
| Age (years) | 52 ± 7.19 | 48 ± 8.42 | P < 0.0001 |
| BMI (kg/m2) | 26.00 ± 2.57 | 22.49 ± 2.54 | P < 0.0001 |
| Current smokers (%) | 212(40.23%) | 216(27.84%) | P < 0.0001 |
| SBP (mmHg) | 119.5 ± 12.00 | 113.1 ± 12.31 | P < 0.0001 |
| DBP (mmHg) | 79.00 ± 8.87 | 73.61 ± 8.69 | P < 0.0001 |
| Hypertension | 142(26.94%) | 84(10.82%) | P < 0.0001 |
| Diabetes mellitus | 45(8.54%) | 17(2.19%) | P < 0.0001 |
| ALT (U/L) | 35.54 ± 22.92 | 20.52 ± 11.51 | P < 0.0001 |
| AST (U/L) | 25.85 ± 10.19 | 20.69 ± 5.76 | P < 0.0001 |
| AST/ALT | 0.85 ± 0.30 | 1.17 ± 0.41 | P < 0.0001 |
| Elevated ALT (> 40 U/L) (%) | 154(29.22%) | 53(6.83%) | P < 0.0001 |
| GGT (U/L) | 39.66 ± 37.51 | 23.05 ± 21.5 | P < 0.0001 |
| TG (mmol/L) | 2.19 ± 1.65 | 1.31 ± 1.12 | P < 0.0001 |
| TC (mmol/L) | 4.83 ± 0.82 | 4.61 ± 0.77 | P < 0.0001 |
| LDL-C (mmol/L) | 3.00 ± 0.74 | 2.80 ± 0.69 | P < 0.0001 |
| HDL-C (mmol/L) | 1.13 ± 0.26 | 1.36 ± 0.34 | P < 0.0001 |
| FBG (mmol/L) | 5.73 ± 1.12 | 5.24 ± 0.71 | P < 0.0001 |
| SUA (umol/L) | 381.8 ± 78.21 | 320.8 ± 77.45 | P < 0.0001 |
| SCr (umol/L) | 74.86 ± 12.96 | 71.12 ± 13.56 | P < 0.0001 |
| PLT (109/I) | 220.6 ± 42.22 | 213.2 ± 43.26 | 0.0023 |
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; ALT: alanine aminotransferase; AST: aspartate aminotransferase; AST/ALT: aspartate aminotransferase/ alanine aminotransferase; Elevated ALT: Elevated Alanine aminotransferase; GGT: glutamyltransferase; TG: triglycerides; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; FBG: fasting blood glucose; SUA: serum uric-acid; SCr: serum creatinine; PLT: platelets
Numerical data were expressed as mean ± standard deviation or median. Categorical data were expressed as percentage